DEF 14A

Company

VACCINEX, INC.

Filed

April 6, 2023

Period of Report

May 11, 2023

Accession Number

0001193125-23-093157

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →